A PHARMACEUTICAL COMPOSITION COMPRISING THE PHYTOCANNABINOIDS CANNABIDIVARIN (CBDV) AND CANNABIDIOL (CBD)
    7.
    发明申请
    A PHARMACEUTICAL COMPOSITION COMPRISING THE PHYTOCANNABINOIDS CANNABIDIVARIN (CBDV) AND CANNABIDIOL (CBD) 审中-公开
    含有PHYCOCANNABINOID CANNABIDIVARIN(CBDV)和CANNABIDIOL(CBD)的药物组合物

    公开(公告)号:US20140243405A1

    公开(公告)日:2014-08-28

    申请号:US14345968

    申请日:2012-09-14

    摘要: This invention relates to a pharmaceutical composition comprising or consisting essentially of the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD). The composition is particularly safe and efficacious for use in the treatment of neurological conditions, characterized by hyper-excitability of the central nervous system, convulsions or seizures such as occur in epilepsy. Preferably the CBDV and the CBD are present with at least one non-cannabinoid component of cannabis such as one or more terpenes or a terpene fraction. More particularly the composition further comprises one or more cannabichromene type compounds. Particularly cannabichromene propyl variant (CBCV) and/or cannabichromene (CBC). More particularly still the composition is absent or substantially absent of other cannabinoids, including in particular tetrahydrocannabinol (THC) and tetrahydrocannabivarin (THCV), which would normally be present in significant amounts in cannabis chemotypes bred to contain a significant amount of CBDV and/or CBD.

    摘要翻译: 本发明涉及包含或基本上由植物大麻素大麻素(CBDV)和大麻二酚(CBD)组成的药物组合物。 该组合物特别安全和有效地用于治疗神经系统疾病,其特征在于中枢神经系统的兴奋性高,惊厥或惊厥如癫痫发作。 优选地,CBDV和CBD存在至少一种大麻素的非大麻素成分,例如一种或多种萜烯或萜烯级分。 更具体地,组合物还包含一种或多种大麻染料型化合物。 特别是异丙基丙基变体(CBCV)和/或大麻色素(CBC)。 更具体地,组合物不存在或基本上不含其他大麻素,包括特别是四氢大麻酚(THC)和四氢大麻素(THCV),其通常以大量化学型存在,以含有显着量的CBDV和/或CBD 。

    Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)

    公开(公告)号:US10729665B2

    公开(公告)日:2020-08-04

    申请号:US14345968

    申请日:2012-09-14

    摘要: This invention relates to a pharmaceutical composition comprising or consisting essentially of the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD). The composition is particularly safe and efficacious for use in the treatment of neurological conditions, characterized by hyper-excitability of the central nervous system, convulsions or seizures such as occur in epilepsy. Preferably the CBDV and the CBD are present with at least one non-cannabinoid component of cannabis such as one or more terpenes or a terpene fraction. More particularly the composition further comprises one or more cannabichromene type compounds. Particularly cannabichromene propyl variant (CBCV) and/or cannabichromene (CBC). More particularly still the composition is absent or substantially absent of other cannabinoids, including in particular tetrahydrocannabinol (THC) and tetrahydrocannabivarin (THCV), which would normally be present in significant amounts in cannabis chemotypes bred to contain a significant amount of CBDV and/or CBD.

    Wireless Priority Service within a Distributed Call Processing Architecture
    9.
    发明申请
    Wireless Priority Service within a Distributed Call Processing Architecture 有权
    分布式呼叫处理架构内的无线优先级服务

    公开(公告)号:US20120033801A1

    公开(公告)日:2012-02-09

    申请号:US12951240

    申请日:2010-11-22

    IPC分类号: H04M3/42

    摘要: A system, method, and call processing component for controlling an order of call processing among a plurality of call processing components. Each call processing component, upon receiving a call request when system resources are not available to process the requested call, creates a real queue entry in its call processing queue and sends a call-queued notification to all other call processing components in the system. The other call processing components in the telecommunication system then create a shadow queue entry in their respective call processing queues as a placeholder for the requested call. When system resources become available and the requested call is next in the queue, the call processing component that received the request de-queues and processes the requested call, and sends a call de-queued notification to the other call processing components. In response, each of the other call processing components removes the placeholder queue entry for the requested call from each call processing component's call processing queue.

    摘要翻译: 一种用于控制多个呼叫处理组件之间的呼叫处理顺序的系统,方法和呼叫处理组件。 当系统资源不可用于处理所请求的呼叫时,每个呼叫处理组件在接收到呼叫请求时,在其呼叫处理队列中创建一个真实的队列条目,并将呼叫排队的通知发送到系统中的所有其他呼叫处理组件。 电信系统中的其他呼叫处理组件然后在其各自的呼叫处理队列中创建一个影子队列条目作为所请求呼叫的占位符。 当系统资源变得可用并且所请求的呼叫在下一个队列中时,接收到请求的呼叫处理组件对队列进行排队并处理所请求的呼叫,并且向其他呼叫处理组件发送呼叫去排队通知。 作为响应,每个其他呼叫处理组件从每个呼叫处理组件的呼叫处理队列中去除所请求的呼叫的占位符队列条目。

    Mobile location recovery for MSC pooling
    10.
    发明授权
    Mobile location recovery for MSC pooling 有权
    MSC集合的移动位置恢复

    公开(公告)号:US08634832B2

    公开(公告)日:2014-01-21

    申请号:US12951549

    申请日:2010-11-22

    摘要: An entity of a wireless telecommunications network having a pool of Mobile Switching Centers (MSCs) and a Home Location Register (HLR). The entity includes a network interface which sends pages to mobiles associated with a failed MSC of the pool of MSC's and experiencing termination isolation and receives responses to the pages from at least some of the mobiles. The entity includes a processing unit which produces a registration having updated location information for each response received by the network interface, the registration sent from the network interface to the HLR to end each mobile's termination isolation for which a response was received by the network interface. A method of an entity of a wireless telecommunications network having a pool of Mobile Switching Centers (MSCs) and a Home Location Register (HLR).

    摘要翻译: 具有移动交换中心(MSC)池和归属位置寄存器(HLR)的无线电信网络的实体。 该实体包括网络接口,该网络接口将页面发送到与MSC的池的故障MSC相关联的移动台并且经历终止隔离并且从至少一些移动台接收对该页面的响应。 该实体包括处理单元,该处理单元产生具有针对由网络接口​​接收的每个响应的更新的位置信息的注册,从网络接口发送到HLR的注册,以结束网络接口接收到响应的每个移动终端隔离。 一种具有移动交换中心(MSC)池和归属位置寄存器(HLR)的无线电信网络的实体的方法。